CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in a fireside chat at the B. Riley Securities Virtual Annual Oncology Investor Conference on Thursday, January 18, 2024 at 1:00 p.m. ET.
Related news for (CTMX)
- Breaking News: MoBot’s Latest Update as of 09/25/25 04:00 PM
- Power Hour Pulse: Spider Silk Surge and Biotech Beats Drive Afternoon Frenzy – These Microcaps Could Explode into Close
- Today’s Top Performers: MoBot’s Market Review 05/28/25 09:00 AM
- CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma
- 5 Hot Trades with News GRYP, ARLSF, CTMX, FRGT, and CAN